跳至主要内容
临床试验/ISRCTN13254422
ISRCTN13254422已完成未知

Achilles tendinopathy management (ATM): A multi-centre placebo-controlled randomised trial comparing platelet rich plasma (PRP) to placebo injection in adults with Achilles tendon pain

niversity of Warwick0 个研究点目标入组 240 人开始时间: 2015年10月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
240

研究概览

简要总结

2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32051317 protocol (added 14/02/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34255009/ (added 14/07/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Provision of written informed consent
  • 2. Aged 18 years or over
  • 3. Pain at the mid-substance of the Achilles tendon for longer than 3 months
  • 4. Ultrasound and/or MRI confirmation of tendinopathy

排除标准

  • 1. Presence of systemic conditions (including: diabetes, rheumatoid arthritis, peripheral vascular disease)
  • 2. Pregnant or actively trying to become pregnant, or breastfeeding at the time of randomisation
  • 3. Have had prior Achilles tendon surgery or rupture on the index side
  • 4. Previous major tendon or ankle injury or deformity to either lower leg
  • 5. Have had a fracture of a long bone in either lower limb in the previous 6 months
  • 6. Have any contraindication to receiving a platelet rich plasma injection (haemodynamic instability, platelet dysfunction syndrome, cancer, septicaemia, systemic use of anticoagulant, local infection at site of the procedure)
  • 7. Are unable to adhere to trial procedures or complete questionnaires
  • 8. Previous randomisation in the present trial
  • Added 19/10/2016:
  • 9. Previous PRP treatment into a tendon.

研究者

发起方
niversity of Warwick

相似试验